반응식
[CH:1]1([C:4]2[CH:5]=[C:6]([C:16]([OH:18])=O)[C:7]3[CH:12]=[N:11][N:10]([CH:13]([CH3:15])[CH3:14])[C:8]=3[N:9]=2)[CH2:3][CH2:2]1.Cl.[NH2:20][CH2:21][C:22]1[C:23](=[O:32])[NH:24][C:25]([CH:29]2[CH2:31][CH2:30]2)=[CH:26][C:27]=1[CH3:28].ON1C2N=CC=CC=2N=N1.C(Cl)CCl.CN1CCOCC1>O.CS(C)=O>[CH:1]1([C:4]2[CH:5]=[C:6]([C:16]([NH:20][CH2:21][C:22]3[C:23](=[O:32])[NH:24][C:25]([CH:29]4[CH2:30][CH2:31]4)=[CH:26][C:27]=3[CH3:28])=[O:18])[C:7]3[CH:12]=[N:11][N:10]([CH:13]([CH3:14])[CH3:15])[C:8]=3[N:9]=2)[CH2:2][CH2:3]1참가 물질
실험 절차
To a 4 mL solution of DMSO were sequentially added 6-cyclopropyl-1-(1-methylethyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid (0.11 g, 0.448 mmol), 3-(aminomethyl)-6-cyclopropyl-4-methyl-2(1H)-pyridinone hydrochloride (0.106 g, 0.493 mmol), 1-hydroxy-7-azabenzotriazole (0.073 g, 0.538 mmol), EDC (0.103 g, 0.538 mmol), and then N-methylmorpholine (0.197 mL, 1.79 mmol) via syringe. After stirring overnight at room temperature, the suspension was diluted with 50 mL of water and stirred for 15 min. After standing at room temperature for 15 min., the reaction mixture was filtered and the collected solid washed with additional water. The solid was then dried in a vacuum oven at 45° C. for 4 h. The product was obtained as 0.165 g (89%). LCMS E-S (M+H)=406.5. 1H NMR (400 MHz, DMSO-d6) δ ppm 0.76-0.82 (m, 2H), 0.91-0.98 (m, 2H), 1.03-1.12 (m, 4H), 1.46 (d, J=6.82 Hz, 6H), 1.74-1.84 (m, 1H), 2.19 (s, 3H), 2.21-2.31 (m, 1H), 4.34 (d, J=5.05 Hz, 2H), 5.05-5.18 (m, 1H), 5.73 (s, 1H), 7.42 (s, 1H), 8.21 (s, 1H), 8.72 (t, J=4.93 Hz, 1H), 11.61 (br. s., 1H).
후처리
- stirringstirred for 15 min
- waitAfter standing at room temperature for 15 min.
- filtrationthe reaction mixture was filtered
- washthe collected solid washed with additional water
- customThe solid was then dried in a vacuum oven at 45° C. for 4 h
- customThe product was obtained as 0.165 g (89%)
출처 및 근거
- ORD 기록
- ord-da854bcbfe264545ab2f87d6b0d72485
- 출처 데이터셋
- uspto-grants-2014_01
- 특허 번호
- US08637509B2
연결된 노트
불러오는 중…